TSHR and thromboangiitis obliterans: This is also the first paper to assess the prevalence of blocking TSH-R autoantibodies in patients with TAO using a newly developed and validated bioassay which is able to measure both blocking and stimulatory activity (i.e., by virtue of observing negative inhibition) [9].